How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI‐RS 2023: Part 1-Reference-Cited by-同舟云学术

How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI‐RS 2023: Part 1

Published:2024-01-04 Issue: Volume: Page:
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Finazzi Agrò Enrico¹^ORCID,Rosato Eleonora²^ORCID,Wagg Adrian³,Sinha Sanjay⁴^ORCID,Fede Spicchiale Claudia⁵,Serati Maurizio⁶^ORCID,Mancini Vito⁷^ORCID,de Rijk Mathijs⁸^ORCID,Tarcan Tufan⁹^ORCID,Wein Alan¹⁰,Abrams Paul¹¹^ORCID,Bou Kheir George¹²

Affiliation:

1. Department of Surgical Sciences, University of Rome Tor Vergata and Urology Unit Policlinico Tor Vergata University Hospital Rome Italy

2. School of specialization in Urology, Policlinico Tor Vergata University Hospital University of Rome Tor Vergata and Urology Unit Rome Italy

3. Department of Medicine University of Alberta Edmonton Alberta Canada

4. Department of Urology Apollo Hospital Hyderabad India

5. Department of Urology, University Hospital Monklands NHS Lanarkshire Airdrie UK

6. Department Obstetrics and Gynecology, Urogynecology Unit University of Insubria Varese Italy

7. Urology and renal transplantation Unit, Urinary incontinence center Policlinico di Foggia Hospital and University of Foggia Foggia Italy

8. Department of Urology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University Medical Center Maastricht University Maastricht The Netherlands

9. Marmara University School of Medicine Istanbul, Turkey and Koç University School of Medicine Istanbul Turkey

10. University of Miami Miller School of Medicine Desai Sethi Institute of Urology Miami Florida USA

11. Department of Urology University of Bristol Bristol UK

12. Gent University Hospital Gent Belgium

Abstract

AbstractIntroductionOveractive bladder (OAB) and Underactive bladder (UAB) could be associated with metabolic syndrome, affective disorders, sex hormone deficiency, changes in urinary microbiota, functional gastrointestinal disorders, or autonomic nervous system dysfunction.ObjectivesThe aim of this Think Tank was to provide a guide on how to investigate OAB and/or detrusor underactivity (DU) patients to better clarify the underlying pathophysiology and possibly personalize the treatment.MethodsA compendium of discussion based on the current evidence related to phenotyping patients with OAB or DU investigating metabolic, neurogical, psychological and gastrointestinal aspects with the aim to personalize the treatment.Results and ConclusionsThe article emphasizes the critical significance of adopting a comprehensive yet tailored approach to phenotyping patients with lower urinary tract symptoms, such as OAB and UAB. The intricate interplay between the lower urinary tract and various factors, metabolic, neurological, psychological, and gastrointestinal can define unique LUT profiles, enabling personalized therapies to replace the one‐size‐fits‐all approach.

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.25377

Reference92 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

2. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction

3. Is coexistent overactive‐underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI‐RS 2019;Mancini V;Neurourol Urodyn,2020

4. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment

5. Harmonizing the Metabolic Syndrome